As we prepare for EULAR 2024, we're excited to share a preview of our ongoing commitment to putting patients first in everything we do. In this exclusive video, UCB’s Head of Global Medical Affairs, Rheumatology, John Ioannou discusses UCB’s proactive strides towards enhancing patient-centricity through: ✨ Innovative Clinical Trial Designs: Engaging directly with patients to make trials more effective 🤝 Direct Patient Involvement: For the first time, patients are contributing their valuable insights on the Benefits Risk Board, influencing meaningful changes and innovative solutions. 🔗 Watch the full video to discover how these initiatives are transforming care and offering new hope to those living with immune-mediated inflammatory diseases. Let’s shape the future of healthcare together! #UCBinRheumatology
UCB’s Post
More Relevant Posts
-
We are delighted to announce one of the biggest milestones in our mission to transform chronic wound care — our CLEANVLU Phase IIa clinical trial report, which demonstrates proof-of-concept and safety of Aurase Wound Gel in humans, has now been published in International Wound Journal. Aurase Wound Gel aims to provide, for the first time, a safe, pain-free, and effective treatment for millions of people suffering from chronic wounds worldwide, and we are incredibly excited to be progressing this product through further Phase II studies. Our Chairman of the Board, Andy Weymann, MD, MBA, comments: “The peer-review publication of our Phase IIa data not only provides important validation to enable further Phase II studies, but also highlights the clinical potential of Aurase Wound Gel to treat millions of patients globally safely and effectively, addressing an urgent and unmet medical need. With this excellent data we are now fundraising to support the next phase of SolasCure’s clinical and product development.” Learn more here: https://lnkd.in/d4EbWtYd #WoundCare #ChronicWounds #ClinicalTrials #HealthCare
-
-
RheumNow Day 4 Recap ACR Convergence 2024 Highlights Catch the latest insights from #ACR24, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care. Join us live and stay at the forefront of rheumatology!
-
RheumNow Day 4 Recap ACR Convergence 2024 Highlights Catch the latest insights from #ACR24, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care. Join us live and stay at the forefront of rheumatology!
RheumNow Day 4 Recap ACR Convergence 2024 Highlights | RheumNow
rheumnow.com
-
Update yourself with the latest articles on Clinical science in Rheumatology from our Editor's pick Happy reading! Check out the complete issue on https://www.iraenl.com/ #iraenewsletter #indianrheumatology #rheumatologyupdate
-
-
Join us for the latest episode in F&P’s educational webinar series, @ Home with Humidified High Flow, featuring Dr. Lisa F. Wolfe of Northwestern Medicine this Friday, 16 August 2024 at 8am (PT), 10am (CT), 11am (ET). To register for this CEU eligible Zoom webinar please visit: https://lnkd.in/gvK9JX8E During this webinar, we will discuss: • Understanding how to identify and define patients appropriate for Humidified High Flow Therapy (HHFT). • Learning the advantages of HHFT for patients with neuromuscular diseases. • Reviewing clinical evidence regarding the mechanisms of HHFT.
-
-
🎥 Catch Our Interview with Hans-Pieter Snels on Wound Care Innovations 🎥 We're happy to share an insightful interview with Hans-Pieter Snels, Clinical and Product Director at DEBx Medical. Hans-Pieter dives into the challenges and breakthroughs in chronic wound care. Here’s a sneak peek: ▶Wound Care Challenges: Hans-Pieter discusses the persistent issue of biofilm infections in chronic wounds. These infections are tough to treat and prevent proper healing. ▶From Traditional to Innovative: Traditional debridement methods often leave bacteria behind, causing recurring infections. Hans-Pieter explains how DEBRICHEM® dehydrates and eradicates biofilms in just 60 seconds, setting a new standard in wound care. ▶Clinical Success: Studies show DEBRICHEM® removes biofilms and promotes granulation, the crucial first step in wound healing. This has been a game-changer for many patients and clinicians. ▶Ongoing Research: Hans-Pieter highlights DEBx Medical's commitment to ongoing research and peer-reviewed publications. The feedback at EWMA 2024 has been fantastic, with many recognizing the potential of DEBRICHEM® in changing the landscape of chronic wound care. Follow DEBx Medical, so you don't miss any inspiring stories: https://lnkd.in/eUdBM2U7 Visit our website to read more case studies. Sign up to receive updates directly to your inbox: https://lnkd.in/e4E3JnRs 🚀 #WoundCare #HealthcareInnovation #BiofilmManagement #DEBxMedical #DEBRICHEM #EWMA2024 #MedicalResearch
-
A UCLH rheumatology team is leading a project to help understand why some young people miss their hospital appointments. They are working closely with the young people themselves to find ways to improve clinic attendance and address health inequalities. Dr Aicha Bouraoui, rheumatology consultant and Pathway to Equity programme lead, said: “Non-attendance is a long-standing issue for the NHS, and we wanted to truly understand the reasons amongst young rheumatology patients behind this. I have loved working with both the clinical team and the young people themselves to tease out some of the issues and work together to find solutions to non-attendance. The Pathway to Equity programme has demonstrated that collaboration between health systems and educational institutions is a key to transforming the lives of our future generations.” Find out more about the programme: https://buff.ly/3OfOy1U
-
-
#ACC24 will bring together experts from across the globe to report on recent progress in #patientcentric cardiovascular #drugdevelopment. Contact Nicola McIntosh or Neil Sheth, MD, FNLA to discuss the best solutions to attract and retain patients for your #clinicaltrial and the best research sites to serve your study needs and target patient population. Learn more about our work in cardiovascular R&D. » https://bit.ly/4ctkgnb
American Congress of Cardiology: 6-8 April in Atlanta
https://globalaes.com
-
VP @ VOZ Advisors | PhD, Pathology, Strategic Partnerships, Business Development and Marketing Strategy, Patient Centricity
Gaining patient insight is critical in a successful clinical study. Better understanding a patient's hesitancy, obstacles, and feedback in the clinical study design can quickly propel that study forward and closer to helping even more patients. It is imperative to not only collect patient insight, but to then incorporate those insights into the study design. The poster below presented at the AOECS 36th General Assembly Conference highlights the importance of collecting patient insights and shifting towards more inclusive patient-centered research. Proud to work for a company that helps plan and execute such critical research and resources and am excited to continue to elevate the patient voice in all we do! #Patientvoice #inclusivityinresearch #Patientengagement #VOZAdvisors
At VOZ Advisors, we are deeply committed to advancing patient engagement to help bridge the gap between patient insights and clinical development. For the last few years, VOZ has supported Takeda with their Celiac Disease Patient Advisory Council (PAC). This council empowers patients to share insights that directly influence clinical trials, ensuring research reflects what truly matters to those living with CeD. This ongoing collaboration represents a shift towards more inclusive, patient-centered research that genuinely addresses the needs and challenges of those impacted by celiac disease. We are honored to share that the results of this ongoing initiative were recently presented at the Association of European Coeliac Societies (AOECS) 36th General Assembly Conference in Madrid. We’re excited to continue elevating patient voices in research and making a meaningful impact on clinical development. #VOZAdvisors #PatientEngagement #CeliacDisease #ClinicalResearch #PatientCentricity
-
Clinical Development Innovator- Medical Affairs Transformer- Translational Medicine Enthusiast - Team Builder - Mediocre-but-perseverant Foilsurfer
7mo👍 John